The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Neal R. Swerdlow

Department of Psychiatry

School of Medicine

University of California San Diego

La Jolla

USA

[email]@ucsd.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, USA. 1996 - 2012

References

  1. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Swerdlow, N.R., Shilling, P.D., Breier, M., Trim, R.S., Light, G.A., Marie, R.S. Psychopharmacology (Berl.) (2012) [Pubmed]
  2. Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats. Swerdlow, N.R., Breier, M.R., Saint Marie, R.L. Psychopharmacology (Berl.) (2011) [Pubmed]
  3. Pramipexole effects on startle gating in rats and normal men. Swerdlow, N.R., Lelham, S.A., Sutherland Owens, A.N., Chang, W.L., Sassen, S.D., Talledo, J.A. Psychopharmacology (Berl.) (2009) [Pubmed]
  4. The effects of memantine on prepulse inhibition. Swerdlow, N.R., van Bergeijk, D.P., Bergsma, F., Weber, E., Talledo, J. Neuropsychopharmacology (2009) [Pubmed]
  5. Effects of the first prepulse on the blink response to a startling noise. Swerdlow, N.R., Talledo, J.A. Behav. Neurosci. (2009) [Pubmed]
  6. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Swerdlow, N.R., Breier, M., Mora, A.B., Ko, D., Shoemaker, J.M. Pharmacol. Biochem. Behav. (2008) [Pubmed]
  7. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Swerdlow, N.R., Weber, M., Qu, Y., Light, G.A., Braff, D.L. Psychopharmacology (Berl.) (2008) [Pubmed]
  8. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Swerdlow, N.R., Shoemaker, J.M., Bongiovanni, M.J., Neary, A.C., Tochen, L.S., Saint Marie, R.L. Pharmacol. Biochem. Behav. (2007) [Pubmed]
  9. Effects of prepulse intensity, duration, and bandwidth on perceived intensity of startling acoustic stimuli. Swerdlow, N.R., Blumenthal, T.D., Sutherland, A.N., Weber, E., Talledo, J.A. Biol. Psychol (2007) [Pubmed]
  10. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Swerdlow, N.R., Sprock, J., Light, G.A., Cadenhead, K., Calkins, M.E., Dobie, D.J., Freedman, R., Green, M.F., Greenwood, T.A., Gur, R.E., Mintz, J., Olincy, A., Nuechterlein, K.H., Radant, A.D., Schork, N.J., Seidman, L.J., Siever, L.J., Silverman, J.M., Stone, W.S., Tsuang, D.W., Tsuang, M.T., Turetsky, B.I., Braff, D.L. Schizophr. Res. (2007) [Pubmed]
  11. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Swerdlow, N.R., Light, G.A., Cadenhead, K.S., Sprock, J., Hsieh, M.H., Braff, D.L. Arch. Gen. Psychiatry (2006) [Pubmed]
  12. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Swerdlow, N.R., Krupin, A.S., Bongiovanni, M.J., Shoemaker, J.M., Goins, J.C., Hammer, R.P. Neuropsychopharmacology (2006) [Pubmed]
  13. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Swerdlow, N.R., Geyer, M.A., Shoemaker, J.M., Light, G.A., Braff, D.L., Stevens, K.E., Sharp, R., Breier, M., Neary, A., Auerbach, P.P. Neuropsychopharmacology (2006) [Pubmed]
  14. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Swerdlow, N.R., Talledo, J., Sutherland, A.N., Nagy, D., Shoemaker, J.M. Neuropsychopharmacology (2006) [Pubmed]
  15. Prepulse-elicited motor reactions do not differ between schizophrenia patients and control subjects. Swerdlow, N.R., Sprock, J., Braff, D.L. Behav. Neurosci. (2006) [Pubmed]
  16. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Swerdlow, N.R., Bongiovanni, M.J., Tochen, L., Shoemaker, J.M. Psychopharmacology (Berl.) (2006) [Pubmed]
  17. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Swerdlow, N.R., Shoemaker, J.M., Kuczenski, R., Bongiovanni, M.J., Neary, A.C., Tochen, L.S., Saint Marie, R.L. Neurosci. Lett. (2006) [Pubmed]
  18. Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm. Swerdlow, N.R., Stephany, N., Wasserman, L.C., Talledo, J., Sharp, R., Minassian, A., Auerbach, P.P. Schizophr. Res. (2005) [Pubmed]
  19. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Swerdlow, N.R., Kuczenski, R., Goins, J.C., Crain, S.K., Ma, L.T., Bongiovanni, M.J., Shoemaker, J.M. Pharmacol. Biochem. Behav. (2005) [Pubmed]
  20. Startle modulation in Caucasian-Americans and Asian-Americans: a prelude to genetic/endophenotypic studies across the 'Pacific Rim'. Swerdlow, N.R., Talledo, J.A., Braff, D.L. Psychiatr. Genet. (2005) [Pubmed]
  21. Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Swerdlow, N.R., Stephany, N.L., Talledo, J., Light, G., Braff, D.L., Baeyens, D., Auerbach, P.P. Biol. Psychol (2005) [Pubmed]
  22. Using animal models to develop therapeutics for Tourette Syndrome. Swerdlow, N.R., Sutherland, A.N. Pharmacol. Ther. (2005) [Pubmed]
  23. Tourette syndrome: current controversies and the battlefield landscape. Swerdlow, N.R. Curr. Neurol. Neurosci. Rep (2005) [Pubmed]
  24. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Swerdlow, N.R., Shoemaker, J.M., Bongiovanni, M.J., Neary, A.C., Tochen, L.S., Saint Marie, R.L. Pharmacol. Biochem. Behav. (2005) [Pubmed]
  25. The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix. Swerdlow, N.R., Shoemaker, J.M., Noh, H.R., Ma, L., Gaudet, I., Munson, M., Crain, S., Auerbach, P.P. Neuroscience (2004) [Pubmed]
  26. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Swerdlow, N.R., Shoemaker, J.M., Crain, S., Goins, J., Onozuka, K., Auerbach, P.P. Pharmacol. Biochem. Behav. (2004) [Pubmed]
  27. Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Swerdlow, N.R., Shoemaker, J.M., Platten, A., Pitcher, L., Goins, J., Auerbach, P.P. Psychopharmacology (Berl.) (2004) [Pubmed]
  28. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Swerdlow, N.R., Shoemaker, J.M., Auerbach, P.P., Pitcher, L., Goins, J., Platten, A. Psychopharmacology (Berl.) (2004) [Pubmed]
  29. Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Swerdlow, N.R., Wasserman, L.C., Talledo, J.A., Casas, R., Bruins, P., Stephany, N.L. Biol. Psychol (2003) [Pubmed]
  30. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Swerdlow, N.R., Platten, A., Hanlon, F.M., Martinez, Z.A., Printz, M.P., Auerbach, P. Neuropsychopharmacology (2003) [Pubmed]
  31. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Swerdlow, N.R., Stephany, N., Wasserman, L.C., Talledo, J., Sharp, R., Auerbach, P.P. Psychopharmacology (Berl.) (2003) [Pubmed]
  32. Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Swerdlow, N.R., Stephany, N., Wasserman, L.C., Talledo, J., Shoemaker, J., Auerbach, P.P. Neuropsychopharmacology (2003) [Pubmed]
  33. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Swerdlow, N.R., Shoemaker, J.M., Platten, A., Pitcher, L., Goins, J., Crain, S. Pharmacol. Biochem. Behav. (2003) [Pubmed]
  34. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Swerdlow, N.R., Eastvold, A., Karban, B., Ploum, Y., Stephany, N., Geyer, M.A., Cadenhead, K., Auerbach, P.P. Psychopharmacology (Berl.) (2002) [Pubmed]
  35. Prestimulus effects on startle magnitude: sensory or motor?. Swerdlow, N.R., Shoemaker, J.M., Stephany, N., Wasserman, L., Ro, H.J., Geyer, M.A. Behav. Neurosci. (2002) [Pubmed]
  36. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Swerdlow, N.R., Shoemaker, J.M., Pitcher, L., Platten, A., Kuczenski, R., Eleey, C.C., Auerbach, P. Behav. Neurosci. (2002) [Pubmed]
  37. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Swerdlow, N.R., Stephany, N., Shoemaker, J.M., Ross, L., Wasserman, L.C., Talledo, J., Auerbach, P.P. Psychopharmacology (Berl.) (2002) [Pubmed]
  38. Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Swerdlow, N.R., Pitcher, L., Noh, H.R., Shoemaker, J.M. Brain Res. (2002) [Pubmed]
  39. Matching strategies for drug studies of prepulse inhibition in humans. Swerdlow, N.R., Eastvold, A., Uyan, K.M., Ploum, Y., Cadenhead, K. Behav. Pharmacol (2001) [Pubmed]
  40. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Swerdlow, N.R., Hanlon, F.M., Henning, L., Kim, Y.K., Gaudet, I., Halim, N.D. Brain Res. (2001) [Pubmed]
  41. Obsessive-compulsive disorder and tic syndromes. Swerdlow, N.R. Med. Clin. North Am. (2001) [Pubmed]
  42. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less. Swerdlow, N.R., Halim, N., Hanlon, F.M., Platten, A., Auerbach, P.P. Brain Res. Bull. (2001) [Pubmed]
  43. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Swerdlow, N.R., Geyer, M.A., Braff, D.L. Psychopharmacology (Berl.) (2001) [Pubmed]
  44. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Swerdlow, N.R., Platten, A., Kim, Y.K., Gaudet, I., Shoemaker, J., Pitcher, L., Auerbach, P. Pharmacol. Biochem. Behav. (2001) [Pubmed]
  45. Effects of pergolide on sensorimotor gating of the startle reflex in rats. Swerdlow, N.R., Platten, A., Shoemaker, J., Pitcher, L., Auerbach, P. Psychopharmacology (Berl.) (2001) [Pubmed]
  46. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Swerdlow, N.R., Taaid, N., Halim, N., Randolph, E., Kim, Y.K., Auerbach, P. Neuroscience (2000) [Pubmed]
  47. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. Swerdlow, N.R., Martinez, Z.A., Hanlon, F.M., Platten, A., Farid, M., Auerbach, P., Braff, D.L., Geyer, M.A. J. Neurosci. (2000) [Pubmed]
  48. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Swerdlow, N.R., Eastvold, A., Gerbranda, T., Uyan, K.M., Hartman, P., Doan, Q., Auerbach, P. Psychopharmacology (Berl.) (2000) [Pubmed]
  49. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Swerdlow, N.R., Braff, D.L., Geyer, M.A. Behav. Pharmacol (2000) [Pubmed]
  50. Cross-species studies of sensorimotor gating of the startle reflex. Swerdlow, N.R., Braff, D.L., Geyer, M.A. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  51. Sex differences in sensorimotor gating of the human startle reflex: all smoke?. Swerdlow, N.R., Geyer, M.A., Hartman, P.L., Sprock, J., Auerbach, P.P., Cadenhead, K., Perry, W., Braff, D.L. Psychopharmacology (Berl.) (1999) [Pubmed]
  52. Preliminary findings with a new Vietnamese Stroop test. Doan, Q.T., Swerdlow, N.R. Percept. Mot. Skills (1999) [Pubmed]
  53. Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Swerdlow, N.R., Taaid, N., Oostwegel, J.L., Randolph, E., Geyer, M.A. Behav. Pharmacol (1998) [Pubmed]
  54. What role models? Commentary on Robbins' homology in behavioural pharmacology: an approach to animal models of human cognition. Swerdlow, N.R. Behav. Pharmacol (1998) [Pubmed]
  55. Latent inhibition in schizophrenia. Swerdlow, N.R., Braff, D.L., Hartston, H., Perry, W., Geyer, M.A. Schizophr. Res. (1996) [Pubmed]
 
WikiGenes - Universities